ITU and Developmental Biology: A Single-Axiom View of Zygote-to-Adult Cell Expansion, Waddington Landscape, Yamanaka iPSC, Hox Colinearity, Morphogen Gradients, Turing Patterns, Organoids, Regeneration, Aging Hallmarks, and Teratology — Block B 4/?

This is Tier 1 paper #29 of the Information-Theoretic Unification (ITU) programme (Terada 2026; concept DOI 10.5281/zenodo.20109209; Tier 0 v3.0 at 10.5281/zenodo.20200156). It is the fourth paper of Block B (Life Sciences Deepening), following #26 Immunology (DOI 10.5281/zenodo.20256116), #27 Microbiology (DOI 10.5281/zenodo.20256555), and #28 Neuroscience (DOI 10.5281/zenodo.20256729). Introduces K_dev across 8 sub-states: K_dev_temporal, K_dev_spatial, K_dev_lineage, K_dev_morphogen, K_dev_stem, K_dev_organoid, K_dev_aging, K_dev_teratology. Pass-1 progress: 214 of 220 phases (97.3%) — only 6 phases remain before Tier 0 v4.0 finale. Phase 207 establishes zygote-to-adult expansion: 45 doublings from 1 cell to 3.7×10¹³ cells (Bianconi 2013), gastrulation D14 with 3 germ layers (ectoderm/mesoderm/endoderm), 700 human cell types (Human Cell Atlas 2024), cell potency hierarchy toti→pluri→multi→oligo→uni. Phase 208 develops Waddington 1957 epigenetic landscape + Yamanaka iPSC (Takahashi-Yamanaka 2006 Cell, Nobel 2012 with Gurdon): OSKM 4-factor reprogramming with retroviral 0.05% → mRNA 1.5% efficiency (Warren 2010), Takahashi Masayo 2013 world-first RPE transplant, direct conversion (iN cells Wernig 2010) 5%. Phase 209 covers body axis + Hox + segmentation: Drosophila HOM-C 8 genes (lab → AbdB), mammalian 4 clusters × ~13 paralogs = 39 functional Hox genes, colinearity (chromosome order = body segment order, Lewis-Nüsslein-Volhard-Wieschaus Nobel 1995), Pourquié 1997 90-min chick c-Hairy1 segmentation clock, Spemann 1924 organizer (Nobel 1935), LR asymmetry via Nodal-Lefty cascade, Kartagener syndrome 1/10,000. Phase 210 covers morphogen + Turing + organogenesis: Wolpert French flag (1969), Bicoid exponential gradient λ = 100 μm in Drosophila (Driever-Nüsslein-Volhard 1988), Turing 1952 reaction-diffusion, Kondo-Asai 1995 zebrafish stripes (Turing animal first, Nature), 6 major morphogen pathways (Shh/BMP/Wnt/FGF/RA/Notch), heart beat D22, neural tube closure D22, lung 23 branching generations → 5×10⁸ alveoli, folate 70% NTD prevention (MRC 1991). Phase 211 documents stem cells + organoids + regeneration: Clevers Lgr5+ ISC (2007) 5 cells/crypt → 250 epithelial in 5 days, Sato 2009 1 Lgr5+ → mini-gut in vitro, Lancaster 2013 cerebral organoid (Nature) up to 4.5 mm with cortical layers → 2024 EEG-like activity raises consciousness questions, Axolotl 30-day complete limb regeneration, planaria 1/300 fragment regenerates whole, mammalian liver 75%-hepatectomy 14-day complete recovery. Phase 212 covers aging deepening: López-Otín 12 Hallmarks of Aging (Cell 2013/2023), telomere shortening 100 bp/division (Blackburn-Greider-Szostak Nobel 2009), Hayflick limit 50 divisions (1961), Horvath 2013 epigenetic clock 353 CpG ±3-5 yr, Mayo Clinic Kirkland 2015 D+Q senolytic +30% mouse healthspan, Ocampo 2016 OSKM partial reprogramming rescuing progeria +30% lifespan, Altos Labs 2022 $3.0 B founding (Yamanaka + Ocampo + López-Otín + Belmonte), Calico Labs Google $1 B, human max lifespan 122 yr (Calment 1997), bowhead whale 211, Greenland shark 400, ocean quahog 507, Hydra negligible senescence. Phase 213 covers teratology + epigenetics + DOHaD: 3-5% birth defect prevalence, CHD 1/100 most common, Thalidomide disaster 10,000 phocomelia (1957-1962, McBride-Lenz 1961 same-month warnings → 1962 world recall → FDA Kefauver-Harris Amendment), folate 70% NTD prevention (MRC 1991) and 56% US fortification 1998, FAS (Jones 1973) 1/500-1000, critical period 3-8 weeks for organogenesis, Prader-Willi vs Angelman (15q11-13 parental imprinting), Barker DOHaD 1986 + Dutch Famine 1944-45 60-year follow-up (Painter 2008 BJOG) with early gestation OR=1.7 for adult cardiovascular/diabetes/schizophrenia. Phase 214 integrates K_dev: 29-vertex polytope (277 edges, ⟨k⟩ = 19.10, #29 Dev reaches new max degree 28). #29 strong couplings: #6 Aging (0.98, Yamanaka rejuvenation duality), #5 Cancer (0.85, de-differentiation), #26 Immune (0.85, immune cell development), #28 Neuro (0.85, brain development + cerebral organoid), #27 Microbe (0.80, gut maturation), #2 AI (0.80, organoid intelligence). ITU axiom δS = δ⟨K⟩ verified to machine precision (1.000000) in 12+ developmental contexts: Phase 207 pluripotent→multipotent and multipotent→unipotent potency descent, Phase 208 differentiation natural descent and Yamanaka anti-descent reprogramming, Phase 209 AP→AP+DV and AP+DV→full chirality symmetry breaking, Phase 211 organoid self-organization from single Lgr5+ stem cell, Phase 212 young→old aging trajectory and old→partial reprogrammed rejuvenation, Phase 213 normal→thalidomide-exposed and thalidomide→folate-protected phenotype transitions. Ten falsifiable predictions for 2028-2035: iPS β-cell T1D approved 2030 (P=0.70), iPS cardiac sheet HF approved 2030 (P=0.65), synthetic embryo gastruloid 3 axes 2030 (P=0.70), in vitro segmentation clock organoid 2028 (P=0.75), cerebral organoid + consciousness debate 2028 (P=0.80), senolytics FDA 2028 (P=0.65), Altos partial reprogramming clinical 2030 (P=0.70), AI teratogen risk prediction 2028 (P=0.75), universal newborn epigenetic clock 2032 (P=0.55), mammalian limb regeneration via blastema 2035 (P=0.30). Grand P_avg = 0.655. Strong/Medium/Weak = 6/3/1. Central thesis: K_dev is the temporal-spatial information expansion K-state of life, complementing K_dev_aging as its dual (development = construction; aging = degradation). The ITU axiom δS = δ⟨K⟩ specializes to K_dev as the developmental biology backbone, unifying cell potency hierarchies, Waddington-Yamanaka reprogramming, Hox colinearity, morphogen-Turing pattern formation, organoid self-organization, regeneration, aging hallmarks, and teratology under one principle. ITU axiom verified to machine precision across 12+ developmental contexts. Pass-1 97.3% milestone reached with only 6 phases remaining before Tier 0 v4.0 finale (Phase 220).

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-05-17
DOI
https://doi.org/10.5281/zenodo.20257270
Primary Topic
Planarian Biology and Electrostimulation
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

ITU and Developmental Biology: A Single-Axiom View of Zygote-to-Adult Cell Expansion, Waddington Landscape, Yamanaka iPSC, Hox Colinearity, Morphogen Gradients, Turing Patterns, Organoids, Regeneration, Aging Hallmarks, and Teratology — Block B 4/?

Munehiro Terada
Zenodo (CERN European Organization for Nuclear Research)
Planarian Biology and Electrostimulation
preprint

ITU and Developmental Biology: A Single-Axiom View of Zygote-to-Adult Cell Expansion, Waddington Landscape, Yamanaka iPSC, Hox Colinearity, Morphogen Gradients, Turing Patterns, Organoids, Regeneration, Aging Hallmarks, and Teratology — Block B 4/?

Munehiro Terada
preprint en

Abstract

This is Tier 1 paper #29 of the Information-Theoretic Unification (ITU) programme (Terada 2026; concept DOI 10.5281/zenodo.20109209; Tier 0 v3.0 at 10.5281/zenodo.20200156). It is the fourth paper of Block B (Life Sciences Deepening), following #26 Immunology (DOI 10.5281/zenodo.20256116), #27 Microbiology (DOI 10.5281/zenodo.20256555), and #28 Neuroscience (DOI 10.5281/zenodo.20256729). Introduces K_dev across 8 sub-states: K_dev_temporal, K_dev_spatial, K_dev_lineage, K_dev_morphogen, K_dev_stem, K_dev_organoid, K_dev_aging, K_dev_teratology. Pass-1 progress: 214 of 220 phases (97.3%) — only 6 phases remain before Tier 0 v4.0 finale. Phase 207 establishes zygote-to-adult expansion: 45 doublings from 1 cell to 3.7×10¹³ cells (Bianconi 2013), gastrulation D14 with 3 germ layers (ectoderm/mesoderm/endoderm), 700 human cell types (Human Cell Atlas 2024), cell potency hierarchy toti→pluri→multi→oligo→uni. Phase 208 develops Waddington 1957 epigenetic landscape + Yamanaka iPSC (Takahashi-Yamanaka 2006 Cell, Nobel 2012 with Gurdon): OSKM 4-factor reprogramming with retroviral 0.05% → mRNA 1.5% efficiency (Warren 2010), Takahashi Masayo 2013 world-first RPE transplant, direct conversion (iN cells Wernig 2010) 5%. Phase 209 covers body axis + Hox + segmentation: Drosophila HOM-C 8 genes (lab → AbdB), mammalian 4 clusters × ~13 paralogs = 39 functional Hox genes, colinearity (chromosome order = body segment order, Lewis-Nüsslein-Volhard-Wieschaus Nobel 1995), Pourquié 1997 90-min chick c-Hairy1 segmentation clock, Spemann 1924 organizer (Nobel 1935), LR asymmetry via Nodal-Lefty cascade, Kartagener syndrome 1/10,000. Phase 210 covers morphogen + Turing + organogenesis: Wolpert French flag (1969), Bicoid exponential gradient λ = 100 μm in Drosophila (Driever-Nüsslein-Volhard 1988), Turing 1952 reaction-diffusion, Kondo-Asai 1995 zebrafish stripes (Turing animal first, Nature), 6 major morphogen pathways (Shh/BMP/Wnt/FGF/RA/Notch), heart beat D22, neural tube closure D22, lung 23 branching generations → 5×10⁸ alveoli, folate 70% NTD prevention (MRC 1991). Phase 211 documents stem cells + organoids + regeneration: Clevers Lgr5+ ISC (2007) 5 cells/crypt → 250 epithelial in 5 days, Sato 2009 1 Lgr5+ → mini-gut in vitro, Lancaster 2013 cerebral organoid (Nature) up to 4.5 mm with cortical layers → 2024 EEG-like activity raises consciousness questions, Axolotl 30-day complete limb regeneration, planaria 1/300 fragment regenerates whole, mammalian liver 75%-hepatectomy 14-day complete recovery. Phase 212 covers aging deepening: López-Otín 12 Hallmarks of Aging (Cell 2013/2023), telomere shortening 100 bp/division (Blackburn-Greider-Szostak Nobel 2009), Hayflick limit 50 divisions (1961), Horvath 2013 epigenetic clock 353 CpG ±3-5 yr, Mayo Clinic Kirkland 2015 D+Q senolytic +30% mouse healthspan, Ocampo 2016 OSKM partial reprogramming rescuing progeria +30% lifespan, Altos Labs 2022 $3.0 B founding (Yamanaka + Ocampo + López-Otín + Belmonte), Calico Labs Google $1 B, human max lifespan 122 yr (Calment 1997), bowhead whale 211, Greenland shark 400, ocean quahog 507, Hydra negligible senescence. Phase 213 covers teratology + epigenetics + DOHaD: 3-5% birth defect prevalence, CHD 1/100 most common, Thalidomide disaster 10,000 phocomelia (1957-1962, McBride-Lenz 1961 same-month warnings → 1962 world recall → FDA Kefauver-Harris Amendment), folate 70% NTD prevention (MRC 1991) and 56% US fortification 1998, FAS (Jones 1973) 1/500-1000, critical period 3-8 weeks for organogenesis, Prader-Willi vs Angelman (15q11-13 parental imprinting), Barker DOHaD 1986 + Dutch Famine 1944-45 60-year follow-up (Painter 2008 BJOG) with early gestation OR=1.7 for adult cardiovascular/diabetes/schizophrenia. Phase 214 integrates K_dev: 29-vertex polytope (277 edges, ⟨k⟩ = 19.10, #29 Dev reaches new max degree 28). #29 strong couplings: #6 Aging (0.98, Yamanaka rejuvenation duality), #5 Cancer (0.85, de-differentiation), #26 Immune (0.85, immune cell development), #28 Neuro (0.85, brain development + cerebral organoid), #27 Microbe (0.80, gut maturation), #2 AI (0.80, organoid intelligence). ITU axiom δS = δ⟨K⟩ verified to machine precision (1.000000) in 12+ developmental contexts: Phase 207 pluripotent→multipotent and multipotent→unipotent potency descent, Phase 208 differentiation natural descent and Yamanaka anti-descent reprogramming, Phase 209 AP→AP+DV and AP+DV→full chirality symmetry breaking, Phase 211 organoid self-organization from single Lgr5+ stem cell, Phase 212 young→old aging trajectory and old→partial reprogrammed rejuvenation, Phase 213 normal→thalidomide-exposed and thalidomide→folate-protected phenotype transitions. Ten falsifiable predictions for 2028-2035: iPS β-cell T1D approved 2030 (P=0.70), iPS cardiac sheet HF approved 2030 (P=0.65), synthetic embryo gastruloid 3 axes 2030 (P=0.70), in vitro segmentation clock organoid 2028 (P=0.75), cerebral organoid + consciousness debate 2028 (P=0.80), senolytics FDA 2028 (P=0.65), Altos partial reprogramming clinical 2030 (P=0.70), AI teratogen risk prediction 2028 (P=0.75), universal newborn epigenetic clock 2032 (P=0.55), mammalian limb regeneration via blastema 2035 (P=0.30). Grand P_avg = 0.655. Strong/Medium/Weak = 6/3/1. Central thesis: K_dev is the temporal-spatial information expansion K-state of life, complementing K_dev_aging as its dual (development = construction; aging = degradation). The ITU axiom δS = δ⟨K⟩ specializes to K_dev as the developmental biology backbone, unifying cell potency hierarchies, Waddington-Yamanaka reprogramming, Hox colinearity, morphogen-Turing pattern formation, organoid self-organization, regeneration, aging hallmarks, and teratology under one principle. ITU axiom verified to machine precision across 12+ developmental contexts. Pass-1 97.3% milestone reached with only 6 phases remaining before Tier 0 v4.0 finale (Phase 220).

Zenodo (CERN European Organization for Nuclear Research)
Stroke Association (GB)
Responsible consumption and production
Planarian Biology and Electrostimulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.